Halldór Jónsson

5.5.2020 | 01:51

Wá?

Scientists Discover Antibody That Blocks Coronavirus From Infecting Cells

Scientists have identified an antibody in a lab that they say can prevent the novel coronavirus from infecting cells. The team hopes the antibody could be used to create treatments for COVID-19, the disease caused by the virus."

"JERUSALEM — Israel has isolated a key coronavirus antibody at its main biological research laboratory, the Israeli defence minister said on Monday, calling the step a "significant breakthrough" toward a possible treatment for the COVID-19 pandemic.

The "monoclonal neutralising antibody" developed at the Israel Institute for Biological Research (IIBR) "can neutralise it (the disease-causing coronavirus) inside carriers' bodies," Defence Minister Naftali Bennett said in a statement.

The statement added that Bennett visited the IIBR on Monday where he was briefed "on a significant breakthrough in finding an antidote for the coronavirus".

It quoted IIBR Director Shmuel Shapira as saying that the antibody formula was being patented, after which an international manufacturer would be sought to mass-produce it."

https://www.newsweek.com/antibody-that-blocks-coronavirus-infecting-cells-discovered-scientists-1501742

https://www.bioinfor.com/peaks-ab-service/?gclid=Cj0KCQjwncT1BRDhARIsAOQF9Lnt3zh8q-xx-Vfr-8p_lHKwQJA7RjJusPxCFoEflsRZAET_EJYJGxUaAk_8EALw_wcB

Þetta er fyrirtæki sem er eitthvað sem vert er að skoða.

"An antibody named 47D11 was found to bind to the spike protein which the novel coronavirus, known as SARS-CoV-2, uses to enter the body, and block it in a way that neutralizes the pathogen."

Call Us: 1-855-885-8288

It is required to obtain the protein sequence of a monoclonal antibody (mAb) for the development of novel biotherapeutics. The need to extensively characterize mAbs at the molecular level presents a unique challenge to drug developers and manufacturers.

PEAKS AB de novo Antibody Protein Sequencing Service provides the answer to this.

Key Features:

Fast: 1 to 3 week(s) turnaround time
Full and In-depth Sequence Coverage: Each amino acid is mapped to more than 20 unique peptides and 100% sequence coverage
Accuracy: Every amino acid in CDRs is confidently supported by pairs of intense fragment ions in at least 10 MS2 scans
Validation by Intact Mass: Intact mass measurements of heavy and light chains for double-confirmation of C-terminal lysine truncation and assembled de novo sequences
3-Tier Leu vs. Ile Differentiation: Differentiation of isoleucine and leucine using advanced EThcD MS method, enzyme digestion specificity and homology database analysis
Interactive Viewer: Investigate details of the report directly from the PEAKS GUI

Wá mar, ef þetta er rétt?

Flokkur: Stjórnmál og samfélag | Breytt s.d. kl. 11:39 | Facebook

Athugasemdir

HUANG NUBO er ógleymanlegur varðandi áhuga hans á KAUPUM á GÍMSTÖÐUM á FJÖLLUM og öllu því ofurlandi, sem átti að fylgja.

ÞJÓÐIN þakkar STYRMI GUNNARSSYNI fyrir skrif hans um NUBO og Kínverja og ákafa ÞEIRRA um kaup á "heilögu" landinu OKKAR.

DETTIFOSS er ekki lengur í OKKAR eign?. HVERT ERUM VIÐ KOMIN af "stjórnleysi".

GÍSLI HOLGERSSON - ICELAND (IP-tala skráð) 5.5.2020 kl. 11:34

Dettifoss? Virkilega Gísli?

Halldór Jónsson, 5.5.2020 kl. 20:12

The statement added that Bennett visited the IIBR on Monday where he was briefed "on a significant breakthrough in finding an antidote for the coronavirus".

It quoted IIBR Director Shmuel Shapira as saying that the antibody formula was being patented, after which an international manufacturer would be sought to mass-produce it.

Continue reading the main story

Halldór Jónsson, 6.5.2020 kl. 02:11

AÐGÁT og FULT STOPP skal setja á sölu Landsinu OKKAR frá fjöru til fjalla.

Annað gildir um "borgarlínu" borgina REYKJAVIK, sem má selja hús og hús til erlendra auðkýfinga upp í "skuldirnar", sem vega hátt í dag hjá höfuðborginni.

GÍSLI HOLGERSSON - ICELAND (IP-tala skráð) 6.5.2020 kl. 11:41